SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 441.20
arrow_upward
+0.87%(+3.80) 1D
Okt 15, 5:29:37 PM GMT+2 · SEK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa SOBI...
Buksan
SEKÂ 437.80
Mataas
SEKÂ 443.20
Mababa
SEKÂ 435.40
Mkt. cap
157.79B
Avg. na dami
255.84K
Dami
219.53K
P/E ratio
117.84
Mataas nang 52-wk
SEKÂ 487.00
Mababa nang 52-wk
SEKÂ 293.60
EPS
SEKÂ 3.74
Mga natitirang share
357.64M
Bilang ng mga empleyado
2K
Buksan
SEKÂ 437.80
Mataas
SEKÂ 443.20
Mababa
SEKÂ 435.40
Mkt. cap
157.79B
Avg. na dami
255.84K
Dami
219.53K
P/E ratio
117.84
Mataas nang 52-wk
SEKÂ 487.00
Mababa nang 52-wk
SEKÂ 293.60
EPS
SEKÂ 3.74
Mga natitirang share
357.64M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Simply Wall Street
·
7 oras ang nakalipas
Tryngolza Backing Could Be A Big Moment For Swedish Orphan Biovitrum Stock
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Tungkol sa Swedish Orphan Biovitrum AB (publ)